Search results
3 days ago · Disclosure statement. Linda-Gail Bekker has received honoraria for advisories from Gilead sciences, ViiV Healthcare and Merck Pty Ltd. Partners. University of Cape Town provides funding as a ...
1 day ago · Royal Bank of Canada reissued their sector perform rating on shares of Gilead Sciences (NASDAQ:GILD – Free Report) in a report issued on Monday, Benzinga reports. The firm currently has a $74.00 price target on the biopharmaceutical company’s stock. A number of other equities research analysts have also weighed in on the stock. Maxim Group […]
5 days ago · GILD. 0.04%. On Monday, RBC (TSX: RY) Capital Markets maintained its Sector Perform rating on Gilead Sciences (NASDAQ: GILD) shares, holding steady with a $74.00 price target. The decision follows a review of recent Phase III clinical trial data for lenacapvir, a drug being developed for HIV pre-exposure prophylaxis (PrEP).
4 days ago · Combining Gilead Sciences' Debt And Its 2.6% Return On Equity Gilead Sciences clearly uses a high amount of debt to boost returns, as it has a debt to equity ratio of 1.44.
4 days ago · Gilead Sciences Inc is a biopharmaceutical company that focuses on the discovery, development, and commercialization of innovative medicines. The company's portfolio includes treatments for...
5 days ago · While we acknowledge the potential of Gilead Sciences, Inc. (NASDAQ:GILD) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns,...
People also ask
What is Gilead Sciences?
Who owns Gilead Sciences Inc (gild)?
Is Gilead Sciences Inc a good stock to buy?
How does Gilead Sciences make money?
3 days ago · See the latest Gilead Sciences GILD stock price (NASDAQ: GILD), related news, valuation, dividends and more to help you make your investing decisions.
